Pain experience during first trimester medical termination of pregnancy: Clinical observation from a cohort of Asian women

Vincent Y.T. Cheung *

Department of Obstetrics and Gynecology, Gleneagles Hospital, The University of Hong Kong, Hong Kong.
 
Research Article
World Journal of Advanced Research and Reviews, 2022, 13(03), 022–024
Article DOI: 10.30574/wjarr.2022.13.3.0199
 
Publication history: 
Received on 25 January 2022; revised on 01 March 2022; accepted on 03 March 2022
 
Abstract: 
Objective: Optimal pain management during medical termination of pregnancy (TOP) remains unclear. This study aimed to suggest practical points to help minimize the intensity of pain of women during first trimester medical TOP.
Methods: A retrospective observational study which reviewed the pain experience and the need for analgesics of 44 Asian women, who underwent first trimester medical TOP.
Results: Nulliparous women had higher pain scores and more likely to need analgesics than multiparous women. Most women requested analgesics between 87.8 and 154.4 min (95% confidence interval) after misoprostol administration.
Conclusions: Prophylactic analgesics should be provided to all nulliparous women undergoing first trimester medical TOP; and if paracetamol is the analgesic of choice, it should be given one hour after vaginal misoprostol administration to optimize pain relief.
 
Keywords: 
First trimester; Medical; Pain management; Termination of pregnancy
 
Full text article in PDF: 
Share this